Literature DB >> 18234701

Longitudinal brain changes in early-onset psychosis.

Celso Arango1, Carmen Moreno, Salvador Martínez, Mara Parellada, Manuel Desco, Dolores Moreno, David Fraguas, Nitin Gogtay, Anthony James, Judith Rapoport.   

Abstract

Progressive losses of cortical gray matter volumes and increases in ventricular volumes have been reported in patients with childhood-onset schizophrenia (COS) during adolescence. Longitudinal studies suggest that the rate of cortical loss seen in COS during adolescence plateaus during early adulthood. Patients with first-episode adolescent-onset schizophrenia show less marked progressive changes, although the number of studies in this population is small. Some studies show that, although less exaggerated, progressive changes are also present in nonschizophrenia early-onset psychosis. The greater loss of brain tissue seen in COS, even some years after the first episode, as compared to adolescent- or adult-onset schizophrenia may be due to variables such as sample bias (more severe, treatment refractory sample of childhood-onset patients studied), a process uniquely related to adolescent development in COS, differential brain effects of drug treatment in this population, clinical outcome, or interactions among these variables. Findings from both cross-sectional studies of first-episode patients and longitudinal studies in COS and adolescent onset support the concept of early-onset schizophrenia as a progressive neurodevelopmental disorder with both early and late developmental abnormalities. Future studies should look for correlates at a cellular level and for pathophysiological explanations of volume changes in these populations. The association of risk genes involved in circuitries associated with schizophrenia and their relationship to developmental trajectories is another promising area of future research.

Entities:  

Mesh:

Year:  2008        PMID: 18234701      PMCID: PMC2632400          DOI: 10.1093/schbul/sbm157

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  72 in total

1.  Focal gray matter changes in schizophrenia across the course of the illness: a 5-year follow-up study.

Authors:  Neeltje E M van Haren; Hilleke E Hulshoff Pol; Hugo G Schnack; Wiepke Cahn; René C W Mandl; D Louis Collins; Alan C Evans; René S Kahn
Journal:  Neuropsychopharmacology       Date:  2007-02-28       Impact factor: 7.853

2.  Sexual dimorphism of brain developmental trajectories during childhood and adolescence.

Authors:  Rhoshel K Lenroot; Nitin Gogtay; Deanna K Greenstein; Elizabeth Molloy Wells; Gregory L Wallace; Liv S Clasen; Jonathan D Blumenthal; Jason Lerch; Alex P Zijdenbos; Alan C Evans; Paul M Thompson; Jay N Giedd
Journal:  Neuroimage       Date:  2007-04-06       Impact factor: 6.556

Review 3.  Brain neuroplasticity in healthy, hyperactive and psychotic children: insights from neuroimaging.

Authors:  Judith L Rapoport; Nitin Gogtay
Journal:  Neuropsychopharmacology       Date:  2007-09-12       Impact factor: 7.853

4.  Dynamic mapping of cortical development before and after the onset of pediatric bipolar illness.

Authors:  Nitin Gogtay; Anna Ordonez; David H Herman; Kiralee M Hayashi; Deanna Greenstein; Cathy Vaituzis; Marge Lenane; Liv Clasen; Wendy Sharp; Jay N Giedd; David Jung; Tom F Nugent; Arthur W Toga; Ellen Leibenluft; Paul M Thompson; Judith L Rapoport
Journal:  J Child Psychol Psychiatry       Date:  2007-09       Impact factor: 8.982

5.  Reduced microstructural integrity of the white matter underlying anterior cingulate cortex is associated with increased saccadic latency in schizophrenia.

Authors:  Dara S Manoach; G Avinash Ketwaroo; Frida E Polli; Katharine N Thakkar; Jason J S Barton; Donald C Goff; Bruce Fischl; Mark Vangel; David S Tuch
Journal:  Neuroimage       Date:  2007-05-21       Impact factor: 6.556

6.  Progressive brain volume loss in schizophrenia over the course of the illness: evidence of maturational abnormalities in early adulthood.

Authors:  Neeltje E M van Haren; Hilleke E Hulshoff Pol; Hugo G Schnack; Wiepke Cahn; Rachel Brans; Inge Carati; Monica Rais; René S Kahn
Journal:  Biol Psychiatry       Date:  2007-06-27       Impact factor: 13.382

7.  Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthood.

Authors:  L A Glantz; J H Gilmore; R M Hamer; J A Lieberman; L F Jarskog
Journal:  Neuroscience       Date:  2007-07-17       Impact factor: 3.590

Review 8.  Developmental mechanisms and experimental models to understand forebrain malformative diseases.

Authors:  A Pombero; L Valdes; C Vieira; S Martinez
Journal:  Genes Brain Behav       Date:  2007-06       Impact factor: 3.449

9.  Cortical brain development in nonpsychotic siblings of patients with childhood-onset schizophrenia.

Authors:  Nitin Gogtay; Deanna Greenstein; Marge Lenane; Liv Clasen; Wendy Sharp; Pete Gochman; Philip Butler; Alan Evans; Judith Rapoport
Journal:  Arch Gen Psychiatry       Date:  2007-07

10.  Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia.

Authors:  Gwenaëlle Douaud; Stephen Smith; Mark Jenkinson; Timothy Behrens; Heidi Johansen-Berg; John Vickers; Susan James; Natalie Voets; Kate Watkins; Paul M Matthews; Anthony James
Journal:  Brain       Date:  2007-08-13       Impact factor: 13.501

View more
  30 in total

1.  Heritability of volumetric brain changes and height in children entering puberty.

Authors:  Inge L C van Soelen; Rachel M Brouwer; G Caroline M van Baal; Hugo G Schnack; Jiska S Peper; Lei Chen; René S Kahn; Dorret I Boomsma; Hilleke E Hulshoff Pol
Journal:  Hum Brain Mapp       Date:  2011-12-03       Impact factor: 5.038

2.  Progressive structural brain changes during development of psychosis.

Authors:  Tim B Ziermans; Patricia F Schothorst; Hugo G Schnack; P Cédric M P Koolschijn; René S Kahn; Herman van Engeland; Sarah Durston
Journal:  Schizophr Bull       Date:  2010-10-07       Impact factor: 9.306

3.  Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.

Authors:  Juan R Bustillo; Hongji Chen; Charles Gasparovic; Paul Mullins; Arvind Caprihan; Clifford Qualls; William Apfeldorf; John Lauriello; Stefan Posse
Journal:  Biol Psychiatry       Date:  2010-10-20       Impact factor: 13.382

4.  Prognosis in schizophrenia and the role of subjectivity.

Authors:  John S Strauss
Journal:  Schizophr Bull       Date:  2008-02-01       Impact factor: 9.306

Review 5.  Developmental vulnerability of synapses and circuits associated with neuropsychiatric disorders.

Authors:  Peter Penzes; Andres Buonanno; Maria Passafaro; Carlo Sala; Robert A Sweet
Journal:  J Neurochem       Date:  2013-05-22       Impact factor: 5.372

6.  Level and pattern of neuropsychological functioning in early-onset psychoses.

Authors:  D-M Walker; P J Standen
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10-12       Impact factor: 4.785

Review 7.  The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits.

Authors:  Andrés Buonanno
Journal:  Brain Res Bull       Date:  2010-08-03       Impact factor: 4.077

Review 8.  Androgenic anabolic steroid exposure during adolescence: ramifications for brain development and behavior.

Authors:  Rebecca L Cunningham; Augustus R Lumia; Marilyn Y McGinnis
Journal:  Horm Behav       Date:  2012-12-26       Impact factor: 3.587

9.  Age at First Episode Modulates Diagnosis-Related Structural Brain Abnormalities in Psychosis.

Authors:  Laura Pina-Camacho; Ángel Del Rey-Mejías; Joost Janssen; Miquel Bioque; Ana González-Pinto; Celso Arango; Antonio Lobo; Salvador Sarró; Manuel Desco; Julio Sanjuan; Maria Lacalle-Aurioles; Manuel J Cuesta; Jerónimo Saiz-Ruiz; Miguel Bernardo; Mara Parellada
Journal:  Schizophr Bull       Date:  2015-09-14       Impact factor: 9.306

Review 10.  Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions.

Authors:  Jim van Os; Bart Pf Rutten; Richie Poulton
Journal:  Schizophr Bull       Date:  2008-09-12       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.